{
    "Clinical Trial ID": "NCT00429572",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Allogeneic Transplantation",
        "  Intravenous Fludarabine 30 mg/m^2 daily on days 1-5, and Melphalan 70 mg/m^2 on days 4 and 5 followed by blood stem cell transplant on day 7."
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Recurrent or residual metastatic breast carcinoma",
        "  Zubrod performance status less than 2",
        "  18-60 years old",
        "  Related donor human leukocyte antigen (HLA)-compatible for allogeneic transplantation or unrelated HLA-compatible donor.",
        "  No major organ dysfunction or active infection",
        "Exclusion Criteria: None"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Number of Participants With Tumor Response",
        "  Best response recorded from start of treatment until disease progression/recurrence using World Health Organization (WHO) criteria of Complete Response: disappearance of all disease/symptoms > 4 weeks; Partial response, > 50% reduction in sum of products of diameters of each measurable lesion for more than 4 weeks; Stable Disease, no change in tumor size; and Progressive Disease, appearance of new lesions or > 25% increase in sum of products of diameters of any measurable lesions.",
        "  Time frame: Baseline to measured progressive disease (post study follow-up period 24 months starting from the date of the last drug administration). Data collected every 4 months.",
        "Results 1: ",
        "  Arm/Group Title: Allogeneic Transplantation",
        "  Arm/Group Description: Intravenous Fludarabine 30 mg/m^2 daily on days 1-5, and Melphalan 70 mg/m^2 on days 4 and 5 followed by blood stem cell transplant on day 7.",
        "  Overall Number of Participants Analyzed: 18",
        "  Measure Type: Number",
        "  Unit of Measure: participants  Complete Response: 5",
        "  Stable Disease: 9",
        "  Partial Response: 1",
        "  Progressive Disease: 3"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/19 (0.00%)"
    ]
}